Artificial intelligence (AI) software developer Imbio has finalized a partnership agreement with Medical-Note that will make Imbio's chest CT imaging analysis available across Italy.
The collaboration will make quantitative chest CT imaging data available to surgeons, pulmonologists, radiologists, and their patients through Medical-Note's range of software and applications.
The two firms will offer a software package called Lung-Note that will feature Imbio's Lung Density Analysis and Lung Texture Analysis tools, both of which support diagnosis and treatment decisions for conditions like chronic obstructive pulmonary disease/emphysema and fibrotic disease, the company said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
